Physiological function of the angiotensin AT1a receptor in bone remodeling

Journal of Bone and Mineral Research

Volumn 26, Issue 12, 2011, Pages 2959-2966

  Kaneko, Keiko ^a   Ito, Masako ^b   Fumoto, Toshio ^a   Fukuhara, Ryoji ^a   Ishida, Junji ^c   Fukamizu, Akiyoshi ^c   Ikeda, Kyoji ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

ANGIOTENSIN RECEPTOR; BONE FORMATION; BONE RESORPTION; KNOCKOUT MOUSE; RENIN ANGIOTENSIN SYSTEM

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; CARBOXY TERMINAL TELOPEPTIDE; LEPTIN; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RNA; STROMAL CELL DERIVED FACTOR 1ALPHA;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MASS; BONE REMODELING; BONE TURNOVER; CELL DIFFERENTIATION; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; FEMUR; HORMONE BLOOD LEVEL; IMAGE ANALYSIS; MALE; METAPHYSIS; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OVARIECTOMY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; THREE DIMENSIONAL IMAGING; TIBIA; TRABECULAR BONE;

AGING; ANIMALS; BONE AND BONES; BONE REMODELING; CELL DIFFERENTIATION; ESTROGENS; GENE EXPRESSION REGULATION; HYPOTENSION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, BIOLOGICAL; ORGAN SIZE; OSTEOBLASTS; OSTEOCLASTS; PHENOTYPE; POLYDIPSIA; POLYURIA; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 81855193731     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.501     Document Type: Article

References (34)

1. Vattikuti R, Towler DA,. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab. 2004; 286 (5): E686-96. (Pubitemid 38506938)
2. Abedin M, Tintut Y, Demer LL,. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol. 2004; 24 (7): 1161-70. (Pubitemid 38880003)
3. Hofbauer LC, Schoppet M,. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA. 2004; 292 (4): 490-5. (Pubitemid 38988958)
4. Khosla S,. The bone and beyond: a shift in calcium. Nat Med. 2011; 17 (4): 430-1.
5. Peach MJ,. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev. 1977; 57 (2): 313-70. (Pubitemid 8097628)
6. Paul M, Poyan Mehr A, Kreutz R,. Physiology of local renin-angiotensin systems. Physiol Rev. 2006; 86 (3): 747-803. (Pubitemid 44033382)
7. Hunyady L, Catt KJ,. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol. 2006; 20 (5): 953-70.
8. Nouet S, Nahmias C,. Signal transduction from the angiotensin II AT2 receptor. Trends Endocrinol Metab. 2000; 11 (1): 1-6. (Pubitemid 30395452)
9. Asaba Y, Ito M, Fumoto T, Watanabe K, Fukuhara R, Takeshita S, Nimura Y, Ishida J, Fukamizu A, Ikeda K,. Activation of renin-angiotensin system induces osteoporosis independently of hypertension. J Bone Miner Res. 2009; 24 (2): 241-50.
10. Shimizu H, Nakagami H, Osako MK, Hanayama R, Kunugiza Y, Kizawa T, Tomita T, Yoshikawa H, Ogihara T, Morishita R,. Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J. 2008; 22 (7): 2465-75. (Pubitemid 351948664)
11. Sugaya T, Nishimatsu S, Tanimoto K, Takimoto E, Yamagishi T, Imamura K, Goto S, Imaizumi K, Hisada Y, Otsuka A, et al. Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem. 1995; 270 (32): 18719-22.
12. Fukamizu A, Sugimura K, Takimoto E, Sugiyama F, Seo MS, Takahashi S, Hatae T, Kajiwara N, Yagami K, Murakami K,. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem. 1993; 268 (16): 11617-21. (Pubitemid 23168109)
13. Ito M, Nakayama K, Konaka A, Sakata K, Ikeda K, Maruyama T,. Effects of a prostaglandin EP4 agonist, ONO-4819, and risedronate on trabecular microstructure and bone strength in mature ovariectomized rats. Bone. 2006; 39 (3): 453-9. (Pubitemid 44149263)
14. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R,. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010; 25 (7): 1468-86.
15. Takeshita S, Kaji K, Kudo A,. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res. 2000; 15 (8): 1477-88. (Pubitemid 30484517)
16. Hiramatsu K, Asaba Y, Takeshita S, Nimura Y, Tatsumi S, Katagiri N, Niida S, Nakajima T, Tanaka S, Ito M, Karsenty G, Ikeda K,. Overexpression of gamma-glutamyltransferase in transgenic mice accelerates bone resorption and causes osteoporosis. Endocrinology. 2007; 148 (6): 2708-15. (Pubitemid 46984813)
17. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, Martin TJ, Suda T,. Osteoblastic cells are involved in osteoclast formation. Endocrinology. 1988; 123 (5): 2600-2.
18. Casas JP, Chua W, Loukogeorgakis S, Vallance P, Smeeth L, Hingorani AD, MacAllister RJ,. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet. 2005; 366 (9502): 2026-33. (Pubitemid 41773378)
19. Paszty C, Turner CH, Robinson MK,. Sclerostin: a gem from the genome leads to bone-building antibodies. J Bone Miner Res. 2010; 25 (9): 1897-904.
20. O'Brien CA, Plotkin LI, Galli C, Goellner JJ, Gortazar AR, Allen MR, Robling AG, Bouxsein M, Schipani E, Turner CH, Jilka RL, Weinstein RS, Manolagas SC, Bellido T,. Control of bone mass and remodeling by PTH receptor signaling in osteocytes. PLoS One. 2008; 3 (8): e2942.
21. Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak-Heinrich J, Bellido TM, Harris SE, Turner CH,. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem. 2008; 283 (9): 5866-75.
22. Karsenty G, Oury F,. The central regulation of bone mass, the first link between bone remodeling and energy metabolism. J Clin Endocrinol Metab. 2010; 95 (11): 4795-801.
23. Glass DA 2nd, Karsenty G,. In vivo analysis of Wnt signaling in bone. Endocrinology. 2007; 148 (6): 2630-4. (Pubitemid 46984774)
24. Williams BO, Insogna KL,. Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone. J Bone Miner Res. 2009; 24 (2): 171-8.
25. Ducy P, Karsenty G,. The two faces of serotonin in bone biology. J Cell Biol. 2010; 191 (1): 7-13.
26. Cassis LA, English VL, Bharadwaj K, Boustany CM,. Differential effects of local versus systemic angiotensin II in the regulation of leptin release from adipocytes. Endocrinology. 2004; 145 (1): 169-74. (Pubitemid 38094512)
27. Porter JP, Potratz KR,. Effect of intracerebroventricular angiotensin II on body weight and food intake in adult rats. Am J Physiol Regul Integr Comp Physiol. 2004; 287 (2): R422-8. (Pubitemid 38970297)
28. Cassis LA, Marshall DE, Fettinger MJ, Rosenbluth B, Lodder RA,. Mechanisms contributing to angiotensin II regulation of body weight. Am J Physiol. 1998; 274 (5 Pt 1): E867-76.
29. Kouyama R, Suganami T, Nishida J, Tanaka M, Toyoda T, Kiso M, Chiwata T, Miyamoto Y, Yoshimasa Y, Fukamizu A, Horiuchi M, Hirata Y, Ogawa Y,. Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptor. Endocrinology. 2005; 146 (8): 3481-9. (Pubitemid 41065022)
30. Grobe JL, Grobe CL, Beltz TG, Westphal SG, Morgan DA, Xu D, de Lange WJ, Li H, Sakai K, Thedens DR, Cassis LA, Rahmouni K, Mark AL, Johnson AK, Sigmund CD,. The brain Renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance. Cell Metab. 2010; 12 (5): 431-42.
31. Cervenka L, Mitchell KD, Oliverio MI, Coffman TM, Navar LG,. Renal function in the AT1A receptor knockout mouse during normal and volume-expanded conditions. Kidney Int. 1999; 56 (5): 1855-62. (Pubitemid 29518186)
32. Yu X, Huang Y, Collin-Osdoby P, Osdoby P,. Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration. J Bone Miner Res. 2003; 18 (8): 1404-18. (Pubitemid 41070795)
33. Izu Y, Mizoguchi F, Kawamata A, Hayata T, Nakamoto T, Nakashima K, Inagami T, Ezura Y, Noda M,. Angiotensin II type 2 receptor blockade increases bone mass. J Biol Chem. 2009; 284 (8): 4857-64.
34. Benigni A, Corna D, Zoja C, Sonzogni A, Latini R, Salio M, Conti S, Rottoli D, Longaretti L, Cassis P, Morigi M, Coffman TM, Remuzzi G,. Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest. 2009; 119 (3): 524-30.